| Groups
Treatment/Dose (mg/mL) |
Glucose
(mM) |
Insulin
(μU/ml) |
Homeostatic insulin
resistance index
(HOMA‐IR) |
| Normal Control |
5.85±0.42 |
3.10± 0.11 |
0.82±0.09 |
| Control + CAMBA (25mg/kg) |
5.48±0.61 |
3.18± 0.27 |
0.79±0.05
|
| Control +CAMBA (50mg/kg) |
5.14± 0.34 |
3.33± 0.15 |
0.77± 0.03 |
| Diabetic Control |
21.52± 2.60** |
1.67± 0.06** |
1.63± 0.07**
|
| Diabetic + CAMBA (25mg/kg) |
8.15± 2.07** |
2.03± 0.10** |
0.75± 0.04*
|
| Diabetic + CAMBA (50mg/kg) |
6.41± 0.59** |
2.10±0.09** |
0.61± 0.08**
|
| Diabetic +Glibenclamide(5mg/kg) |
5.36±0.59** |
2.83±0.18** |
0.69±0.06** |
Values are given as mean ± SD for groups of eight animals each. Homeostatic index of insulin resistance HOMA-IR), calculated by glucose (mM) x insulin (µU/ml)/22.5. Values are statistically significant at *P<0.05 & **P<0.01. Diabetic control rats were compared with normal control rats. Experimental groups were compared with the diabetic control rats